TNFα*2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans

Clinical and Experimental Immunology

Volumn 115, Issue 2, 1999, Pages 350-355

  Wattavidanage, J ^a   Carter, R ^b   Perera, K L R L ^a   Munasingha, A ^a   Bandara, S ^c   Mcguinness, D ^b   Wickramasinghe, A R ^a   Alles, H K ^a   Mendis, K N ^a   Premawansa, S ^a,d  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c Anuradhapura General Hospital   (Sri Lanka)

^d UNIVERSITY OF COLOMBO   (Sri Lanka)

Author keywords

Malaria infectious disease pathogenesis; Plasmodium falciparum; TNF polymorphisms

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; GENE EXPRESSION; MALARIA; NONHUMAN; PATHOGENESIS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SRI LANKA; ALLELE; EPIDEMIOLOGY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HETEROZYGOTE; HUMAN; IMMUNOLOGY; MALARIA FALCIPARUM; RISK FACTOR;

ALLELES; CAUSALITY; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HUMANS; LYMPHOTOXIN-ALPHA; MALARIA, FALCIPARUM; POLYMORPHISM, GENETIC; RISK FACTORS; SRI LANKA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032896154     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00804.x     Document Type: Article

References (29)

1. 1 Wilson AG, Gordon C, di Giovine FS, de Vries N, van der Putte LBA, Emery P, Duff GW. A genetic association between systemic lupus erythematosus and tumour necrosis factor alpha. Eur J Immunol 1994; 24:191-5.
2. 2 Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. New Eng J Med 1978; 298:869-71.
3. 3 Svejgaard A, Jakobsen BK, Platz P et al. HLA associations in insulin-dependent diabetes: search for heterozygosity in different groups of patients from a homogeneous population. Tissue Antigens 1986; 28:237-44.
4. 4 Hill AVS, Allsopp CEM, Kwiatkowski D et al. Common West African HLA antigens are associated with protection from severe malaria. Nature 1991; 352:595-600.
5. 5 McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371:508-11.
6. 6 Smith CA. The TNF receptor superfamily of cellular and viral proteins-activation, costimulation and death. Cell 1994; 76:959-62.
7. 7 Grau GE, Lambert PH, Vassalli P, Piguet PF. Tumour necrosis factor cachectin as an effector of T-cell dependent immunopathology. Int Rev Exp Pathol 1993; 34 (Part B):159-71.
8. 8 Beutler B, Cerami A. The biology of cachectin/TNF-a primary mediator of the host response. Ann Rev Immunol 1989; 7:625-55.
9. 9 Kwiatkowski D, Molyneux ME, Stephens S. Anti-TNF therapy inhibits fever in cerebral malaria. Quart J Med 1993; 86:91-98.
10. 10 Karunaweera ND, Grau GE, damage CP, Carter R, Mendis KN. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc Natl Acad Sci USA 1992; 89:3200-3.
11. 11 Mendis KN, Carter R. Clinical disease and pathogenesis in malaria. Parasitol Today 1995; 11 (Suppl.)PTI 1-16.
12. 12 Clark IA, Gray KM, Rockett EJ, Cowden WB, Rocken KA, Ferrante A, Aggarwal BB. Increased lymphotoxin in human malarial serum and the ability of this cytokine to increase plasma interleukin-6 and cause hypoglycaemia in mice: implications for malarial pathology. Trans Roy Soc Trop Med Hyg 1991; 86:602-7.
13. 13 Pociot F, Briant L, Jongeneel CV et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23:224-31.
14. 14 Messer G, Spengler U, Jung MC, Honold G, Blomer K, Pape GR. Riethmuller G, Weiss EH. Polymorphic structure of the tumor necrosis factor (TNF) locus: an Ncol polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-β production. J Exp Med 1991; 173:209-19.
15. 15 Bouma GB, Crusius JBA, Oudkerk Pool M et al. Secretion of tumour necrosis factor α and lymphotoxin α in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Stand J Immunol 1996; 43:456-63.
16. 16 Nedospasov SA, Shakov AN, Turetskaya RL et al. Tandem arrangement of genes coding for tumor necrosis factor (TNF-α) and lymphotoxin (TNF-β) in the human genome. Cold Spring Harbor Symp Quant Biol 1986; 51:611-24.
17. 17 Spies T, Morton CC, Nedospasov SA, Fiers W, Pious D, Strominger JL. Genes for tumor necrosis factor α and β are linked to the human major histocompatibility complex. Proc Natl Acad Sci, USA 1986; 83: 8699-702.
18. 18 Jongeneel CV, Briant L, Udalova IA, Sevin A, Nedospasov SA, Cambon-Thomsen A. Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes. Proc Natl Acad Sci, USA 1991; 88:9717-21.
19. 19 Nedospasov SA, Udalova IA, Kuprash DV, Turetskaya RL. DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus: numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-β) gene. J Immunol 1991; 147:1053-9.
20. 20 Abraham LJ, Du DC, Zahedi K, Dawkins RL, Whitehead AS. Haplotypic polymorphisms of the TNFB gene. Immunogenetics 1991; 33:50.
21. 21 Ferencik S, Lindemann M, Horsthemke B, Grosse-Wilde H. A new restriction fragment length polymorphism of the human TNF-B gene detected by Asp HI digest. Eur J Immunogenetics 1992; 19:425-30.
22. 22 Wilson AG, di Giovine FS, Blakmore AIF, Duff GW. Single base change in the human tumour necrosis factor alpha (TNFα) gene detected by Ncol restriction of PCR product. Hum Mol Genecs 1992; 1:353.
23. 23 D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994; 39:150-4.
24. 24 Warrell DA, Molyneux ME, Beals PF. Severe and Complicated malaria. Trans Roy Soc Trop Med Hyg 1990; 84 (Suppl. 2): 1-65.
25. 25 Alles HK. PhD Thesis, University of Colombo 1998.
26. 26 Snounou G, Viriyakosol S, Zhu XP, Jarry W, Pinheiro L, Rosario VE, Thaithong S, Brown KM. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol 1993; 61:315-20.
27. 27 Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd edn. New York: Cold Spring Harbor Laboratory Press, 1989.
28. 28 Campbell DA, Nelson S, Madhok R, Field M, Gallagher G. TNF Nco-1 RFLP is not an independent risk factor in rheumatoid arthritis. Eur J Immunol 1994; 21:461-7.
29. 29 Bouma G, Xia B, Crusius JBA, Bioque G, Koutroubakis I, Von Blomberg BME, Meuwissen SGM, Pena AS. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 1996; 103:391-6.